PhD
-
VUSN to begin testing next generation device
BRISBANE, Australia and CARLSBAD, Calif., July 18, 2016 /PRNewswire/ — ImpediMed Limited (ASX:IPD) announces that it is partnering with Vanderbilt University School of Nursing for a series of patient and clinician human factors testing for the company’s next generation technology platform. Under the direction of Principal Investigator… Read MoreJul. 19, 2016
-
Mickelson Receives VUSN PhD Student Excellence in Writing Award
BRISBANE, Australia and CARLSBAD, Calif., July 18, 2016 /PRNewswire/ — ImpediMed Limited (ASX:IPD) announces that it is partnering with Vanderbilt University School of Nursing for a series of patient and clinician human factors testing for the company’s next generation technology platform. Under the direction of Principal Investigator… Read MoreOct. 26, 2015
-
Advanced Device Improves Health and Costs for Patients With Lymphedema
BRISBANE, Australia and CARLSBAD, Calif., July 18, 2016 /PRNewswire/ — ImpediMed Limited (ASX:IPD) announces that it is partnering with Vanderbilt University School of Nursing for a series of patient and clinician human factors testing for the company’s next generation technology platform. Under the direction of Principal Investigator… Read MoreOct. 21, 2015
-
PhD Student Support Fund Update
BRISBANE, Australia and CARLSBAD, Calif., July 18, 2016 /PRNewswire/ — ImpediMed Limited (ASX:IPD) announces that it is partnering with Vanderbilt University School of Nursing for a series of patient and clinician human factors testing for the company’s next generation technology platform. Under the direction of Principal Investigator… Read MoreNov. 14, 2014